EUVIMEDEUVIMED entdecken
Open Access

Intrinsic STAT4 Expression Controls Effector CD4 T Cell Migration and Th17 Pathogenicity

Ashlyn A Buzzelli iD, Ian L McWilliams, Boyoung Shin iD, Morgan T Bryars, Laurie E Harrington iD

The Journal of Immunology · 2023

DOI: 10.4049/jimmunol.2200606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Ashlyn A Buzzelli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Encephalomyelitis, Autoimmune, Experimental. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIAMS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Effector CD4 T cells are central to the development of autoimmune chronic inflammatory diseases, yet factors that mediate pathogenicity remain ill-defined. Single-nucleotide polymorphisms in the human STAT4 locus are associated with susceptibility to multiple autoimmune disorders, and Stat4 is linked to the pathogenic Th17 gene signature; however, Th17 cells differentiate independently of STAT4. Hence the interplay between STAT4 and CD4 T cell function, especially Th17 cells, during autoimmune disease is unclear. In this article, we demonstrate that CD4 T cell–intrinsic STAT4 expression is essential for the induction of autoimmune CNS inflammation in mice, in part by regulating the migration of CD4 T cells to the inflamed CNS. Moreover, unbiased transcriptional profiling revealed that STAT4 controls the expression of >200 genes in Th17 cells and is important for the upregulation of genes associated with IL-23–stimulated, pathogenic Th17 cells. Importantly, we show that Th17 cells specifically require STAT4 to evoke autoimmune inflammation, highlighting, to our knowledge, a novel function for STAT4 in Th17 pathogenicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD4-Positive T-LymphocytesEncephalomyelitis, Autoimmune, ExperimentalHumansMiceAnimalsTh17 CellsTh1 CellsVirulenceInflammationCell DifferentiationSTAT4 Transcription Factor

Substanzen

STAT4 protein, humanSTAT4 Transcription FactorStat4 protein, mouse

Autor:innen und Institutionen

  • Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL.

ORCID-Profile: Ashlyn A Buzzelli, Boyoung Shin, Laurie E Harrington

Förderung

  • NIAID NIH HHS
  • NIAMS NIH HHS
  • NIDDK NIH HHS
  • HHS | National Institutes of Health
  • American Heart Association
  • National Multiple Sclerosis Society

Zitieren

APA

Buzzelli, A. A., McWilliams, I. L., Shin, B., Bryars, M. T., & Harrington, L. E. (2023). Intrinsic STAT4 Expression Controls Effector CD4 T Cell Migration and Th17 Pathogenicity. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200606

Vancouver

Buzzelli AA, McWilliams IL, Shin B, Bryars MT, Harrington LE. Intrinsic STAT4 Expression Controls Effector CD4 T Cell Migration and Th17 Pathogenicity. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200606

BibTeX
@article{Buzzelli2023,
  author = {Buzzelli, Ashlyn A and McWilliams, Ian L and Shin, Boyoung and Bryars, Morgan T and Harrington, Laurie E},
  title = {Intrinsic STAT4 Expression Controls Effector CD4 T Cell Migration and Th17 Pathogenicity},
  journal = {The Journal of Immunology},
  year = {2023},
  doi = {10.4049/jimmunol.2200606}
}
Kostenlos starten →